The present study demonstrates that human SK-N-SH neuroblastoma cells, differentiated by retinoic acid (RA), express functional NMDA receptors and become vulnerable to glutamate toxicity. During exposure to RA, SK-N-SH cells switched from non-neuronal to neuronal phenotype by showing antigenic changes typical of postmitotic neurons together with markers specific of cholinergic cells.
Fig. 1:
Expression of NR1 and NR2B proteins in RAdifferentiated SK-N-SH cells. NR1 immunostaining was slight in control cells (A) but very marked in neuronal cells of RA-treated cultures (B). Western blot analysis confirmed the expression of NR1 and NR2B proteins in RAdifferentiated cultures (RA). Bands corresponding to NR1 (~115 kDa) and NR2B (~180 kDa) were found in extracts from rat hippocampus, run in the same gel as positive control (data not shown).
Fig. 3:
Glutamate-induced excitotoxicity. LDH release was assayed in control (open bars) and RA-treated (black bars) SK-N-SH cells exposed to glutamate (100-500 µM) for 15 min. No modification of LDH release was produced by glutamate in control cultures. In RA-treated cells glutamate caused a dose-dependent increase in extracellular LDH activity. This effect was prevented by 1 µM MK 801 but not by 1 µ M CNQX, both added 5 min before glutamate exposure. Application of 5 mM NMDA for 60 min in the presence of 10 µM glycine was also toxic to RA-differentiated cells. NMDA effect was prevented by 1 µM ifenprodil added 5 min before NMDA. Bars represent the means ± standard error of at least three experiments run in quadruplicate. Wilcoxon's rank sum test was used for the statistical analysis of values. * p < 0.01 versus basal value. 
